Clinical Trials

200 enrolled

Colorectal Neoplasms

NCT00958737 2023-09-29

IDEA

2,000 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT04259944 2023-09-28

Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

140 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT04262635 2023-08-02

C-CLASSIC

80 enrolled

Colorectal Neoplasms

NCT03950154 2023-08-01

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

198 enrolled

Colorectal Neoplasms

NCT05799820 2023-05-25

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

60 enrolled

Colorectal Neoplasms

NCT01898104 2023-03-24

V-shoRT-R3

152 enrolled

Colorectal Neoplasms

NCT05659290 2023-01-06

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

40 enrolled

Colorectal Neoplasms

NCT05016869 2022-08-18

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

48 enrolled

Colorectal Neoplasms

NCT04733963 2022-07-26

Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

112 enrolled

Colorectal Neoplasms

NCT05451719 2022-07-12

Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

116 enrolled

Colorectal Neoplasms

NCT05368051 2022-05-10

Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer

Unknown

30 enrolled

Colorectal Neoplasms

NCT04911517 2022-02-23

Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by TME for LARC.

50 enrolled

Colorectal Neoplasms

NCT04380103 2020-05-08

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

106 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT03448549 2020-03-06

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

1,191 enrolled

Patient Compliance, Colorectal Neoplasms

NCT03813641 2019-09-09

RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)

Colorectal Neoplasms

NCT04008511 2019-07-05

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

54 enrolled

Colorectal Neoplasms

NCT00647530 2019-05-17

FOxTROT

1,053 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT03465202 2018-03-14

Association of Capecitabine Pharmacokinetics and Toxicity With Aging

Phase 4 Unknown

BreastGastrointestinal

Frailty, Breast Neoplasms, Colorectal Neoplasms

NCT01196260 2018-02-20

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

8,000 enrolled

Colorectal Neoplasms

NCT02717923 2017-10-23

A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer

50 enrolled

Colorectal Neoplasms

NCT01308086 2017-08-09

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

2,000 enrolled

Neoplasms, Colorectal Neoplasms

NCT03132025 2017-04-27

Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer

40 enrolled

Colorectal Neoplasms

NCT02893540 2016-09-16

Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC

250 enrolled

Colorectal Neoplasms

NCT02316535 2016-09-13

LcACEC

710 enrolled

Colorectal Neoplasms

NCT02870153 2016-08-19

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

60 enrolled

Colorectal Neoplasms

NCT00058474 2016-03-23

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

1,608 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT02068131 2016-01-05

Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer

30 enrolled

Colorectal Neoplasms

NCT02415829 2015-04-14

Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients

55 enrolled

Colorectal Neoplasms

NCT01157052 2014-10-01

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Phase 1 Unknown

15 enrolled

Colorectal Neoplasms

NCT01880658 2014-02-11

CAMCO

Colorectal Neoplasms

NCT02043821 2014-01-24

Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker

Phase NA Unknown

80 enrolled

Colorectal Neoplasms

NCT00967655 2014-01-10

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

54 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT02027363 2014-01-06

Maintenance Treatment With Capecitabine in Colorectal Cancer Patients

245 enrolled

Colorectal Neoplasms

NCT00442637 2013-12-12

CAIRO3

635 enrolled

Colorectal Neoplasms

NCT01097265 2013-08-12

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

1,500 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00482222 2013-01-23

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

340 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01679327 2012-09-06

Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

NCT01552967 2012-03-28

mXELOX

30 enrolled

Adenocarcinoma, Colorectal Neoplasms

NCT01311050 2011-12-13

A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer

Unknown

46 enrolled

Colorectal Neoplasms

NCT00659022 2011-09-12

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

60 enrolled

Liver Neoplasms, Colorectal Neoplasms

NCT00544011 2011-06-27

Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

47 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00383695 2010-01-13

EXPERT-C

164 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00156975 2009-12-25

Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases

384 enrolled

Colorectal Neoplasms

NCT00997685 2009-10-19

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

110 enrolled

Colorectal Neoplasms

NCT00075556 2009-02-09

Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00303745 2008-07-24

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

78 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00630045 2008-03-06

Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis

392 enrolled

Colorectal Neoplasms

NCT00189683 2005-09-19

Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy